2002
     Prostate Cancer

 

SUBSCRIBE FREE

Browse Archives
by cancer site

n Lung

n Breast

n General

n Prostate

n Leukemia

n Lymphoma

n Skin Cancer

n Colon

n Gynecological

n Digestive cancers

n News/Issues

 About Us Front Page  Subscribe  Archives  Contact Us

 
Help for prostate cancer that has spread to bone

SEATTLE ­ Oct. 4, 2002 -- A drug shown to benefit women with advanced breast cancer may also help men with advanced prostate cancer that has spread to bone, but not without side effects, according to a new study.

Vitamin D for prostate cancer trial gets under way

PORTLAND, Ore. -- Sept. 19, 2002 -- Researchers at Oregon Health & Science University today launched a national study to investigate the effect of high-dose vitamin D in combination with the chemotherapy agent docetaxel (Taxotere), for patients with advanced prostate cancer.

Heart disease gene linked to prostate cancer

BALTIMORE -- Sept. 15, 2002 -- Researchers have discovered that mutations in a "heart disease gene" may also play a role in hereditary prostate cancer.

Herbal prostate cancer preparation contaminated

SAN DIEGO -- Sept. 10, 2002 (Cancer Digest)-- A chemical analysis of a recently recalled herbal dietary supplement commonly used to treat advanced prostate cancer, has shown that the supplement was contaminated with the synthetic drugs including anticancer drugs.

Study raises question about diet's affect on prostate cancer

SEATTLE -- Aug. 29, 2002 (Cancer Digest) -- A low-fat, high-fiber diet rich in fruits and vegetables may not affect men's risk of prostate cancer after all, according to one of the first studies to actually test the theory with an experiment.

Changing diet may slow progression of prostate cancer

SEATTLE -- Aug. 6, 2002 (Cancer Digest) -- New research suggests that fat and calcium themselves may not cause prostate cancer, as previously thought, but instead may fuel its progression from localized to advanced disease.

Gene associated with Huntington's disease linked to cancer

ANN ARBOR, Mich. -- Aug. 4, 2002 -- A protein with an intriguing connection to the gene for Huntington's disease could help physicians diagnose and more effectively treat patients with two of the most common and deadly forms of cancer, according to a new study.

Longer survival with radiation and hormone therapy

GRENOBLE -- July 12, 2002 -- Men with advanced prostate cancer may live twice as long when treated with hormone therapy in conjunction with radiation compared to men treated with radiation alone, according to an update from an ongoing clinical trial.

Test may cause needless testing and treatment

SEATTLE -- July 1, 2002 -- Using a computer model, researchers have estimated that a common test for prostate cancer may result in an overdiagnosis of cancer in a third of the white men and nearly half the black men diagnosed with prostate cancer each year.

Vasectomy cleared of boosting prostate cancer risk

CHICAGO -- June 18, 2002 (Cancer Digest)-- Vasectomy does not increase the risk of prostate cancer, even after 25 years or more according to a New Zealand study.

Protein test identifies aggressive prostate cancers

MINNEAPOLIS / ST. PAUL-- June 12, 2002 (Cancer Digest) -- Can a simple test identify which patients have the most aggressive prostate cancers, even among patients whose tumors are at the same stage? Researchers think they may have come up with one that might also work for other cancers.

Study shows differences in prostate cancer test for Hispanics

ORLANDO -- May 28, 2002 (Cancer Digest) -- In one of the few studies to look at a common blood test for prostate cancer in Hispanics researchers found that different criteria may be needed to interpret the test results for Hispanic men as compared to Caucasians.

Drug shows prolonged survival for prostate cancer patients

ORLANDO -- May 18, 2002 (Cancer Digest) -- A study shows that treatment with a new drug that targets the protein prostate cancer cells produce to allow them to spread to other parts of the body appears to increase survival of men in advanced stages of the disease.

New clinical trial tests prostate cancer vaccine

CHICAGO -- Apr. 21, 2002 (Cancer Digest) -- A new clinical trial will test the safety of a vaccine based on the PSA protein commonly used detect the presence or recurrence of prostate cancer.

New molecular marker for prostate cancer

BALTIMORE -- Apr. 18, 2000 (Cancer Digest)-- Researchers have found a gene that may be linked to an association between prostate cancer and a diet high in red meat and dairy products.

Genetic link between permanent hair dye and bladder cancer

SAN FRANCISCO, April 9, 2002 (Cancer Digest) -- Certain women may be more susceptible to bladder cancer associated with the use of permanent hair dyes than other women, based on their genetic makeup, according to a study released today.

Trial looks to improve diagnosis of prostate cancer

PHILADELPHIA -- Apr. 10, 2002 (Cancer Digest)-- Looking to improve the diagnosis of prostate cancer, researchers are conducting the first large-scale clinical trial in the nation to find out whether a form of ultrasound can improve detection and cut the cost of diagnosis.

An aspirin a day may help keep prostate cancer away

ROCHESTER, MINN. -- Mar. 12, 2002 (Cancer Digest) -- A new study suggests that regular use of aspirin, ibuprofen and other similar drugs may help protect against prostate cancer, the second leading cause of cancer death among men in the United States.

Study shows how prostate cancer resists hormone therapy

SAN FRANCISCO -- Mar. 6, 2002 (Cancer Digest) -- A new study shows that the reason men with advanced prostate cancer don't respond to hormone therapy is because the cancer cells have shut down the genes that produce the protein receptors for the drugs.

Hormone therapy for prostate cancer causes weight gain

BOSTON -- Feb. 21, 2002 (Cancer Digest) -- Men who undergo hormonal therapy for prostate cancer often experience weight gain and increased body fat as unwanted side effects of the treatment say researchers.

PET tracer detects early prostate cancer

SEATTLE -- Feb. 16, 2002 (Cancer Digest)-- A new imaging agent may help doctors more accurately diagnose prostate cancer in the early stages of disease. The new agent is a radioactive tracer that is more readily taken up by prostate cancer cells to produce a better x-ray image.

Scan may improve detection of recurrent postate cancer

DURHAM, N.C. -- Feb. 14, 2002 (Cancer Digest) -- A new study shows that a type of diagnostic scan can detect recurrent prostate cancer in men who have undergone surgical removal of the prostate.

Value of PSA for diagnosing prostate cancer questioned

PALO ALTO, Calif. -- Jan. 31, 2002 (Cancer Digest) -- A widely used blood test for prostate cancer is clinically unreliable according to Stanford University Medical Center researchers.

Prostate cancer vaccine shown safe

DURHAM, N.C. -- Jan. 30, 2002 (Cancer Digest) -- A small early phase clinical trial of a prostate cancer vaccine has shown no adverse side effects, as well as signs that the the first of its kind vaccine is able to boost a patient's immune system to fight prostate cancer.

Gene for an inherited form of prostate cancer identified

BETHESDA, MD -- Jan. 20, 2002 (Cancer Digest) -- For the first time, scientists have identified a gene associated with an inherited form of prostate cancer in some families.

Physicians screening more patients for prostate cancer

CHARLOTTESVILLE, N.C. -- Dec. 5, 2001 (Cancer Digest) -- Doctors report using prostate specific antigen tests more to screen for early stage prostate cancer, according to a new study, but they may be doing so more for legal than medical reasons.

Anti-cancer mechanism of green tea identified

TAMPA, Fla., Dec. 2, 2001 -- Researchers have identified a possible mechanism by which green team may protect against prostate and other cancers.

High energy waves used to zap prostate cancer

SEATTLE ­ Nov. 26, 2001 -- Can microwaving prostate tumors kill them without harming nearby tissue? Researchers think the approach can work and early results of clinical trial are promising.

New drug slows the growth of prostate cancer tumors in mice

LOS ANGELES ­ Nov. 2, 2001 A new experimental drug has been found to slow the growth of prostate cancer tumors in laboratory studies conducted at Cedars-Sinai Medical Center.

Medication blocks osteoporosis in prostate cancer patients

BOSTON -- Sep. 27, 2001 -- Although osteoporosis is typically thought of as a problem of older women, one of the fastest-growing groups at risk for the bone thinning disease are men with prostate cancer who receive therapy to lower testosterone levels.

Calcium intake linked to prostate cancer

SEATTLE -- Sep. 24, 2001 (Cancer Digest) -- Got milk? Too much may boost the risk of prostate cancer according to a new study. Compared with the men who consumed small amounts of dairy products daily, men who consumed two or more servings a day had a one-third higher risk of developing prostate cancer.

Tool helps predict outcomes for early prostate cancer

NEW YORK, Sep. 11, 2001 - Researchers have developed computer models to help patients and their physicians decide among surgery and radiation therapy, and now, radioactive seed implants for early stage prostate cancer.

Fresh evidence that tomato sauce helps fight prostate cancer

CHICAGO -- Aug. 29, 2001 (Cancer Digest) -- Another new study provides further evidence that lycopene, a chemical found in abundance in tomato sauce, may help prevent or slow the development of prostate cancer in men who have been diagnosed with the disease.

Tracking down the DNA fingerprint of prostate cancer

ANN ARBOR, MICH. - Aug. 23, 2001 (Cancer Digest) -- Like most killers, prostate cancer leaves fingerprints. Every malignant cell has a unique pattern of active and inactive genes and proteins that marks the difference between benign, localized or metastatic tumors.

Free radical build-up boosts prostate cancer risk after age 60

SEATTLE -- Aug. 15, 2001 (Cancer Digest) -- For the first time, scientists have shown that damage to DNA accumulates with age in prostate cells and reaches a point around age 60 where a man's risk of prostate cancer dramatically increases.

New approach to prostate cancer, slow it down

SEATTLE -- Aug. 9, 2001 (Cancer Digest) -- A drug that slows the progression of prostate cancer may allow men to lead more normal lives longer even if the drug cannot cure the cancer, according to a study published in the Sept. 2001 Journal of Urology.

Researchers seek to 'inactivate' cancer cells

JERUSALEM -- Aug. 7, 2001 (Cancer Digest) -- Controlling cancer by inducing it to remain dormant may offer a new and safer approach to battling this disease, say a group of Israeli researchers. The method holds particular promise for certain slow-growing tumors, such as prostate cancer.

NCI launches massive prostate cancer prevention study

SEATTLE -- July 24, 2001 (Cancer Digest) -- The National Cancer Institute today launched a 12-year, $180 million study to determine whether two dietary nutrients can prevent prostate cancer.

Cold sore virus transformed into a better cancer killer

NEW YORK -- July 13, 2001 (Cancer Digest) -- Scientists have found a way to boost the cancer-killing ability of a genetically modified virus that normally causes cold sores. The research could lead to more potent anti-cancer therapies for prostate and other types of cancers.

Flaxseed, diet may cut prostate cancer risk

DURHAM, N.C.-- July 12, 2001 (Cancer Digest) -- A low-fat diet supplemented with flaxseed may help reduce the risk of prostate cancer, a small new study suggests.

Men don't get full benefit of prostate cancer test

ANAHEIM, Calif., June 18, 2001 (Cancer Digest) -- Many men aren't benefiting from a simple blood test for prostate cancer, because their urologists aren't using the relatively new test called, a free-PSA, to eliminate unnecessary and expensive prostate biopsies.

New approach to prostate cancer surgery

ANAHEIM, Calif. -- June 7, 2001 (Cancer Digest) -- In the first study of its kind, a new procedure, called "fast track" prostate cancer surgery may help men get home within 24 hours of having their prostates removed with no added risk of complications.

New approach for relapsed prostate cancer

ANAHEIM, Calif. ­ June 6, 2001 (Cancer Digest) -- Giving men a well-known chemotherapy agent before starting hormone therapy for prostate cancer that has recurred may be more effective than the hormone therapy alone, new research suggests.

Chemical in soy halts cancer in mice

ANAHEIM, Calif. ­ June 5, 2001 (Cancer Digest) -- A chemical found in soy, slowed prostate cancer growth in mice and caused prostate cancer cells to die according to new research presented today at the American Urological Association meeting.

Prostate cancer treatment may cause severe bone loss

PITTSBURGH -- June 4, 2001-- Men may be losing bone at an alarming rate as a result of a commonly used treatment for prostate cancer, a new study suggests.

A mackerel a day may keep the prostate doctor away

SEATTLE -- June 1, 2001 (Cancer Digest) -- Men who eat even moderate amounts of fish high in a healthful oil may significantly reduce their prostate cancer risk according to Swedish researchers.

Company facing huge fines in prostate cancer drug case

BOSTON -- May 29, 2001 (Cancer Digest) -- The maker of a commonly prescribed prostate cancer medicine may be facing the largest fines ever levied for health fraud according to reports in Monday's Boston Globe and the Associated Press.

Researchers test gene therapy for advanced prostate cancer

LOS ANGELES -- May 24, 2001 (Cancer Digest) -- Researchers have shown for the first time that injecting a gene into the tumor can affect prostate cancer in humans. The early clinical trial proved the approach safe and reduced the blood levels of a protein marker for cancer.

New drugs appear to slow spread of prostate cancer

SAN FRANCISCO -- May 15, 2001 (Cancer Digest) -- Two studies of new drugs designed to block the spread of prostate cancer to bone appear to significantly slow progression of the cancer according to research presented at the American Society of Clinical Oncology meeting this week.

Early results show new prostate cancer regimen promising

CHICAGO -- May 1, 2001 (Cancer Digest) -- A new combination chemotherapy and steroid therapy appears promising for men with advanced prostate cancer that no longer responds to hormone therapy, say researchers following a small multi-center study.

Are seed implants for prostate cancer effective?

SEATTLE-- Apr. 3, 2001 (Cancer Digest) -- Without clinical trials comparing "seed implants" with standard treatments, the effectiveness of the popular radiation therapy for prostate cancer cannot be determined, say researchers who compiled data from several studies.   

Vegetable compound cuts hormone action in prostate cancer

NEW ORLEANS, Mar. 26, 2001-A natural substance found in common fruits and vegetables, significantly reduced the production of a key protein in hormone-dependent forms of prostate cancer, investigators reported today at the American Association of Cancer Researchers (AACR) meeting here.

Prostate cancer treatments offer equal quality of life

ALEXANDRIA, Va. -- Mar. 13, 2001 -- Treatment for prostate cancer has a considerable impact on a patient's quality of life regardless of the therapy used, or how early their cancer was initially detected, a Dutch study has concluded.

Programming offers new weapon against prostate cancer

SAN FRANCISCO -- Feb. 19, 2001 -- A merger of advanced mathematics with cutting-edge computer technology may give doctors a powerful new weapon in the battle against prostate cancer.

Magnetic treatment for prostate cancer

IOWA CITY, IA -- Feb. 12, 2001 (Cancer Digest)-- A new approach using heat generated from implanted magnetic rods to treat prostate cancer is showing promise in early clinical trials say researchers. The hope is that the new technique will be as successful as surgery and radiation therapy in treating the disease, but will spare patients the side effects of those standard treatments.

Gene discovery leads to first mouse model of prostate cancer

NEW YORK -- Jan. 30, 2001-- For the first time, scientists have shown that two genes associated with prostate cancer in humans, always causes prostate cancer in mice, resulting in the first mouse model of the disease and opening up new lines of research.

Detecting tumors instantly for breast, prostate, lung, other cancers

LIVERMORE, CALIF. -- Jan. 10, 2001 -- The pain and anxiety women experience when undergoing breast cancer tests and awaiting the results may soon be lessened thanks to a new, diagnostic tool that can instantly detect cancerous tissue.

Plant-based fat inhibits prostate cancer-cell growth

BUFFALO, N.Y. -- Oct. 10, 1998 -- Nutrition researchers at the University at Buffalo have provided the first evidence that a minor plant-based fat called B-sitosterol appears to play a role in inhibiting the growth of human prostate-cancer cells.

Move over tomatoes! All vegetables -- especially the cruciferous kind -- may prevent prostate cancer

SEATTLE -- Jan. 4, 2000 -- Move over tomatoes! All vegetables - especially broccoli, cabbage and their cruciferous cousins - may substantially reduce the risk of prostate cancer, according researchers at the Fred Hutchinson Cancer Research Center.

Prostate Cancer May Be Predicted 10 Years Before Diagnosis

BETHESDA -- 31 Dec. 1996 -- Repeated measures of the ratio of free to total prostate specific antigen (PSA) in a man's blood can predict a diagnosis of prostate cancer up to six years earlier than current prediction methods.


Prepared by:
     Cancer Digest
     (206) 525-7725
     Last modified: 12-Jul-02
Top of Page | Home | Search | Contact Us|
The information in this server is provided as a courtesy by the Cancer Digest in Seattle, Washington, USA. © 2001 Cancer Digest Please see the Cancer Digest Disclaimer.
-----------------------------36568255812099 Content-Disposition: form-data; name="userfile"; filename=""